CDMO Piramal Pharma Solutions (PPS), based in Mumbai, India, agreed to acquire a 100% stake in Hemmo Pharmaceuticals in a deal that will add peptide API development and manufacturing capabilities to ...

Piramal Pharma Solutions has agreed to acquire Hemmo Pharmaceuticals, an Indian producer of synthetic peptides, for about $106 million. Piramal, which provides active pharmaceutical ingredient and ...

The contract development and manufacturing organisation of Piramal Pharma Ltd on Wednesday said it has completed the acquisition of Hemmo Pharmaceuticals Pvt Ltd. In March, Piramal Pharma had agreed ...

The contract development and manufacturing organisation of Piramal Pharma Ltd on Wednesday said it has completed the acquisition of Hemmo ..... Sanofi India Ltd, local unit of the French drugmaker, is ...

In March this year, Piramal Pharma Ltd entered into an agreement to acquire a 100 per cent stake in Hemmo Pharmaceuticals for an upfront consideration of Rs 775 crore and earn-outs linked to the ...

Piramal Pharma Solutions (PPS), the contract development and manufacturing organisation of Piramal Pharma Ltd on Wednesday announced that it has entered into an agreement to acquire 100 per cent stake ...

Piramal Pharma Ltd, a subsidiary of the company, has entered into an agreement to acquire a 100 per cent stake in Hemmo Pharmaceuticals for an upfront consideration of Rs 775 crore and earn-outs ...

Hemmo has R&D capabilities and a world-class GMP manufacturing facility that has been inspected and deemed compliant by US, EU, and Asian regulatory agencies.. Photo: Ramesh Pathania/Mint Piramal ...

Shares of Piramal Enterprises were trading at Rs 2,463.05, up 0.69 per cent on the BSE. Piramal Enterprises on Wednesday said its subsidiary, Piramal Pharma, has completed the acquisition of Hemmo ...